Ignite Creation Date:
2025-12-24 @ 11:48 PM
Ignite Modification Date:
2025-12-30 @ 10:14 AM
Study NCT ID:
NCT01263951
Status:
UNKNOWN
Last Update Posted:
2021-10-26
First Post:
2010-11-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib Alone
Sponsor:
Thomas Jefferson University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-11
Start Date Type:
None
Primary Completion Date:
2021-02-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-05
Completion Date Type:
ESTIMATED
First Submit Date:
2010-11-29
First Submit QC Date:
None
Study First Post Date:
2010-12-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-18
Last Update Post Date:
2021-10-26
Last Update Post Date Type:
ACTUAL